New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine
Large-scale epidemiological studies have demonstrated that heart rate (HR) is an independent risk factor, increasing total, sudden and cardiovascular mortality risk. Ivabradine specifically binds to sinus node (SN) f-channels and reduces HR. Due to its specific SN action and selective If current inh...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1417 |
Summary: | Large-scale epidemiological studies have demonstrated that heart rate (HR) is an independent risk factor, increasing total, sudden and cardiovascular mortality risk. Ivabradine specifically binds to sinus node (SN) f-channels and reduces HR. Due to its specific SN action and selective If current inhibition, ivabradine dose-responsively reduces HR at rest and maximal physical exertion, without changes in mean blood pressure. It has been shown that ivabradine is not only well-tolerated, but also possesses anti-anginal and anti-ischemic effects, as potent as those for modern angina treatment agents: beta-blockers and calcium antagonists. |
---|---|
ISSN: | 1728-8800 2619-0125 |